Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	109613
Country	China

Received	2025-05-19 08:42
Peer-Review Started	2025-05-19 08:43
To Make the First Decision
Return for Revision	2025-05-27 03:43
Revised	2025-06-10 13:46
Second Decision	2025-07-04 02:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-07-04 07:44
Articles in Press	2025-07-04 07:44
Publication Fee Transferred	2025-06-12 09:31
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-08-01 07:52
Publish the Manuscript Online	2025-08-14 05:49

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Progress of immune checkpoint inhibitors in gastric cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Ji-Yun Wan, Duo Zhang, Xiang-Hua Wu, Hao Yang and Chao Dong
Funding Agency and Grant Number
Corresponding Author	Chao Dong, MRCP, Research Fellow, Department of Hemodialysis, The Affiliated Taian City Central Hospital of Qingdao University, No. 29 Long Tan Road, Taian 271000, Shandong Province, China. dongchao689@163.com
Key Words	Gastric cancer; Immune checkpoint inhibitors; Combination therapy; Chemotherapy; Targeted therapy
Core Tip	Gastric cancer (GC) is a serious threat to human health. Immunotherapy is one of the important ways of clinical treatment of GC. Among them, immune checkpoint inhibitors (ICIs) have been applied in clinical practice, and the research on the combination therapy of ICIs has shown good therapeutic effect and lower treatment toxicity. This minireview summarizes the progress of immune ICIs in GC, discusses current individualized strategies, and explores future development directions.
Publish Date	2025-08-14 05:49
Citation	<p>Wan JY, Zhang D, Wu XH, Yang H, Dong C. Progress of immune checkpoint inhibitors in gastric cancer. <i>World J Gastrointest Oncol</i> 2025; 17(8): 109613</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i8/109613.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i8.109613

Full Article (PDF)	WJGO-17-109613-with-cover.pdf
Manuscript File	109613_Auto_Edited_073543.docx
Answering Reviewers	109613-answering-reviewers.pdf
Audio Core Tip	109613-audio.mp3
Conflict-of-Interest Disclosure Form	109613-conflict-of-interest-statement.pdf
Copyright License Agreement	109613-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	109613-non-native-speakers.pdf
Peer-review Report	109613-peer-reviews.pdf
Scientific Misconduct Check	109613-scientific-misconduct-check.png
Scientific Editor Work List	109613-scientific-editor-work-list.pdf
CrossCheck Report	109613-crosscheck-report.pdf